Results

Total Results: 554 records

Showing results for "kidney disease".

101. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
     September 29, 2011 - Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … disease, or other comorbid disease o Angiographic-specific factors such as access site (radial or … disease FRISC-II Fast Revascularization during Instability in Coronary Artery Disease trial MACE

102. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
     January 01, 2011 - The most important risk factor for CIN, chronic kidney disease, is rising, driven in part by the increasing

103. March 2nd Mitigating Racial Bias in Healthcare Algorithms Public Meeting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-2.pdf
     May 15, 2023 - health officials can make informed decisions to ensure equity and personalized care for patients with kidney … diseases ► Keep laboratories, clinicians, and other kidney health professionals apprised ► Identify … Comprehensive Approach Establishing a Task Force to reassess the Inclusion of Race in Diagnosing Kidney … Diseases A joint statement from the National Kidney Foundation and the American Society of Nephrology

104. Omega 3 Fatty Acids and Cardiovascular Disease - Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
     April 02, 2015 - disease, other nutrients or supplements, and drugs (e.g., statins, aspirin, diabetes drugs, hormone … CAD = coronary artery disease, CHF = congestive heart failure, CKD = nondialysis-dependent chronic kidney … disease, CMS = cardiometabolic syndrome, CVA = cerebrovascular accident (stroke), CVD = cardiovascular … disease) Adults with clinical CVD (e.g., history of myocardial infarction, angina, transient ischemic … disease), Dyslipidemia.

105. Icd-Categories-Prevalence-Reimbursement Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
     January 01, 2011 - hypertension, heart disease, pulmonary disorders, spine-related care, gastrointestinal upset, and kidney … disease.2,4,5,6 Chronic diseases disproportionately affect older adults.2 Among the Medicare population … increases in recent spending are attributable to diabetes, chronic obstructive pulmonary disease, kidney … disease, hyperlipidemia, hypertension, mental disorders, and arthritis. … disease (585) 1,637,128 13,765,987 1,805.9 630-677 Complications of pregnancy, childbirth

106. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
     October 01, 2022 - Results 10 4.3 SIHD and Chronic Kidney Disease We identified one fair-quality systematic review, … Abbreviations: AMI=acute myocardial infarction CKD=chronic kidney disease; CV=cardiovascular; DES=drug … Optimal treatment strategies for coronary artery disease in patients with advanced kidney disease: … Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. … OMT (HR 1.54 [95% CI 0.91– 2.62]); p=NS SIHD and Chronic Kidney Disease Reference: Yong et

107. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
     February 01, 2013 - Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … − Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease … − Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease … − Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease?

108. Comparative Effectiveness of Treatments for Restless Legs Syndrome | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/restless-legs/research-protocol
     December 16, 2011 - Severity Comorbidities Etiology (i.e., primary or secondary RLS) Iron Status Pregnancy End-stage kidney … disease Interventions Pharmacological treatments (dopaminergic agents, sedative-hypnotics, anticonvulsants

109. Topic 0556 CE of Treatments for Diabetic Peripheral Neuropathy NSD SJ clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0658-140831.pdf
     July 19, 2014 - . § Risk factors for the development of the condition include smoking, kidney disease, and a long

110. Treatment of Non-metastatic Muscle-invasive Bladder Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
     July 21, 2014 - characteristics, such as age, sex, ethnicity, performance status, or medical comorbidities such as chronic kidney … disease? … characteristics, such as age, sex, ethnicity, performance status, or medical comorbidities such as chronic kidney … disease? … disease?

111. TND-555-09-03-2013 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
     January 01, 2013 - A1C), other diabetes-related outcomes such as episodes of hypoglycemia, and complications including kidney … disease, amputation, blindness, cardiovascular outcomes (e.g., heart disease, stroke), comorbidities

112. Bladder-Cancer-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
     June 01, 2015 - disease? … disease? … disease? … disease? … disease?

113. Update of Comparative Effectiveness of Lipid-Modifying Agents | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
     May 17, 2013 - A1c ≥6.5 percent; a fasting glucose ≥126 mg/dL; and newly diagnosed acute kidney injury and chronic kidney … disease (investigator defined) Timing and Study Design Randomized controlled trial (RCT) of any … endarterectomy; CER = comparative effectiveness review; CHD = coronary heart disease; CKD = chronic kidney … disease; CVD = cardiovascular disease; DPP-4 = dipeptidyl peptidase IV; ER = extended release; FDA = … Outcomes We will include diabetes mellitus and acute kidney injury/chronic kidney disease as potential

114. Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
     January 01, 2014 - their etiology and treatment.18-21 Related conditions include acute myocardial infarction, chronic kidney … disease, heart failure, ischemic heart disease, cataract, glaucoma, stroke, and atrial fibrillation … cancer 3.4 3.5 3.6 3.3 Lung cancer 1.3 1.3 2.6 1.2 Prostate cancer 4.2 4.2 6.7 4.2 CKD = Chronic kidney … disease, AMI = Acute myocardial infarction, AFIB = Atrial fibrillation, COPD = Chronic obstructive … disease and heart failure.

115. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Arthritis and Nontraumatic Joint Disease AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 01: Arthritis and Nontraumatic Joint Disease Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither…

116. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/clinician
     July 25, 2017 - with diabetes, cardiometabolic syndrome, hypertension, dyslipidemia, or nondialysis-dependent chronic kidney … disease) or with established CVD (e.g., a history of myocardial infarction, angina, stroke, or arrhythmia

117. Evidence Summary for Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
     December 01, 2020 - Evidence Summary for Treatments for Acute Pain: A Systematic Review Comparative Effectiveness Review Number 240 Treatments for Acute Pain: A Systematic Review Evidence Summary Main Points Background and Purpose The purpose of this review is to evaluate the effectiveness and comparative …

118. Bladder-Cancer-Muscle-Invasive Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
     July 21, 2014 - characteristics, such as age, sex, ethnicity, performance status, or medical comorbidities such as chronic kidney … disease? … disease? … characteristics, such as age, sex, ethnicity, performance status, or medical comorbidities such as chronic kidney … disease?

119. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - ≥ 6.5 percent; a fasting glucose ≥126 mg/dL; and newly diagnosed acute kidney injury and chronic kidney … disease (investigator defined) • Timing and Study Design o Randomized controlled trial (RCT) of … endarterectomy; CER = comparative effectiveness review; CHD = coronary heart disease; CKD = chronic kidney … disease; CVD = cardiovascular disease; DPP-4 = dipeptidyl peptidase IV; ER = extended release; FDA … disease as potential harms

120. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - Source: www.effectivehealthcare.ahrq.gov Published Online: November 15, 2012 1 Evidence-based Practice Center Technical Brief Protocol Project Title: Enzyme Replacement Therapy for Lysosomal Storage Disorders Amendment Date(s) if applicable: August 28, 2012 (Amendments Details–see Section VII) I. …